Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07266571 · ClinicalTrials.gov registry record · NA
Pycnogenol (French Maritime Pine Bark) for the Treatment of Gulf War Illness
A NA study, sponsored by University of Alabama at Birmingham.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07266571 is a NA study that has not yet begun recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 20 participants.
The verdict
NCT07266571, a NA study, has not yet begun recruiting, sponsored by University of Alabama at Birmingham.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine how pycnogenol may reduce Gulf War Illness (GWI) symptom severity. The study will also examine the safety of this treatment and determine the optimal dosage. The investigators believe that GWI involves inflammation in the body and brain that causes fatigue, pain, cognitive disruption, and other symptoms. Botanicals that reduce inflammation may help treat GWI.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Pycnogenol, 100mg
- DIETARY_SUPPLEMENT Pycnogenol, 200mg
- DIETARY_SUPPLEMENT Pycnogenol, 400mg
- DIETARY_SUPPLEMENT Pycnogenol, 600mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2027-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07266571
The ClinicalTrials.gov registry entry for NCT07266571 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT07266571 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07266571 about?
NCT07266571 is a clinical study titled "Pycnogenol (French Maritime Pine Bark) for the Treatment of Gulf War Illness". The purpose of this research study is to determine how pycnogenol may reduce Gulf War Illness (GWI) symptom severity. The study will also examine the safety of this treatment and determine the optimal dosage. The investigators believe that GWI involves inflammation in the body and brain that causes ...
What is the current status of trial NCT07266571?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-08-01. Estimated completion is 2027-08-01.
What interventions are being tested in trial NCT07266571?
The interventions under investigation include: Placebo (OTHER), Pycnogenol, 100mg (DIETARY_SUPPLEMENT), Pycnogenol, 200mg (DIETARY_SUPPLEMENT), Pycnogenol, 400mg (DIETARY_SUPPLEMENT), Pycnogenol, 600mg (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07266571?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.